Cargando…
Prevention approaches in a preclinical canine model of Alzheimer’s disease: benefits and challenges
Aged dogs spontaneously develop many features of human aging and Alzheimer’s disease (AD) including cognitive decline and neuropathology. In this review, we discuss age-dependent learning tasks, memory tasks, and functional measures that can be used in aged dogs for sensitive treatment outcome measu...
Autores principales: | Davis, Paulina R., Head, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968758/ https://www.ncbi.nlm.nih.gov/pubmed/24711794 http://dx.doi.org/10.3389/fphar.2014.00047 |
Ejemplares similares
-
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease
por: Bloomingdale, Peter, et al.
Publicado: (2022) -
Preclinical and clinical issues in Alzheimer's disease drug research and development
por: Mancuso, Cesare, et al.
Publicado: (2014) -
Yuan-Hu Zhi Tong Prescription Mitigates Tau Pathology and Alleviates Memory Deficiency in the Preclinical Models of Alzheimer’s Disease
por: Iyaswamy, A., et al.
Publicado: (2020) -
Neuroprotective Potentials of Panax Ginseng Against Alzheimer’s Disease: A Review of Preclinical and Clinical Evidences
por: Li, Jing, et al.
Publicado: (2021) -
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
por: Kong, Fanjing, et al.
Publicado: (2023)